Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q3 2025 · 10-Q
Revenue$21.18M$21.18M+53.8% vs Q3 2024 Net Income$32.86M$32.86M+15.1% vs Q3 2024 EPS Diluted$0.69$0.69+6.2% vs Q3 2024 Operating Cash Flowderived$62,532,000+28.6% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end